SCHEMBL4484764

SCHEMBL4484764

CC=Cc1ccc(C(=O)N(CC)CC)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.44
HSP90AA1 P07900 4/20 0.43
HSP90AB1 P08238 3/20 0.43
ALDH1A1 P00352 3/20 0.41
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
CNR2 P34972 1/20 0.37
SLC6A3 Q01959 1/20 0.36
GCGR P47871 1/20 0.36
PYGL P06737 1/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4484759 1.00 CYP3A4 (0.44) CYP3A4HSP90AA1HSP90AB1ALDH1A1MAPT
SCHEMBL3558642 0.84 CYP3A4 (0.46) CYP3A4HSP90AA1HSP90AB1ALDH1A1MAPT
SCHEMBL3727793 0.78 ALDH1A3 (0.40) HSP90AA1HSP90AB1ALDH1A1L3MBTL1NPC1
SCHEMBL471670 0.76 HPGD (0.51) CYP3A4HSP90AA1HSP90AB1ALDH1A1MAPT
SCHEMBL16305344 0.75 CHRM2 (0.56) CYP3A4HSP90AA1HSP90AB1ALDH1A1MAPT
SCHEMBL3552169 0.75 USP2 (0.52) CYP3A4HSP90AA1HSP90AB1ALDH1A1MAPT
SCHEMBL3555893 0.75 CYP3A4 (0.49) CYP3A4HSP90AA1HSP90AB1ALDH1A1MAPT
SCHEMBL4462445 0.73 CYP3A4 (0.50) CYP3A4HSP90AA1HSP90AB1ALDH1A1MAPT
SCHEMBL29956454 0.73 CYP3A4 (0.47) CYP3A4HSP90AA1HSP90AB1ALDH1A1MAPT
SCHEMBL4037887 0.73 CYP3A4 (0.47) CYP3A4HSP90AA1HSP90AB1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572805-B2 Pyrrolo(oxo)isoquinolines as 5HT ligands BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-11 US disclosed
US-20060014777-A1 Pyrrolo(oxo)isoquinolines as 5HT ligands BRISTOL-MYERS SQUIBB COMPANY 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014777-A1 Pyrrolo(oxo)isoquinolines as 5HT ligands HTR2B, OPRD1, HTR1B CYP3A4 1738/4885HSP90AA1 4652/4885HSP90AB1 4404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.